Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Perrigo Company plc (PIG.F)

Compare
23.43
+1.23
+(5.54%)
As of 8:25:20 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,373,400
4,373,400
4,655,600
4,451,600
4,138,700
Cost of Revenue
2,830,700
2,830,700
2,975,200
2,996,200
2,722,500
Gross Profit
1,542,700
1,542,700
1,680,400
1,455,400
1,416,200
Operating Expense
1,230,800
1,230,800
1,396,300
1,334,000
815,800
Operating Income
311,900
311,900
284,100
121,400
600,400
Net Non Operating Interest Income Expense
-187,800
-187,800
-173,800
-156,000
-125,000
Other Income Expense
-204,800
-204,800
-118,600
-104,500
-216,700
Pretax Income
-80,700
-80,700
-8,300
-139,100
258,700
Tax Provision
80,000
80,000
-3,900
-8,200
389,600
Net Income Common Stockholders
-171,800
-171,800
-12,700
-140,600
-68,900
Diluted NI Available to Com Stockholders
-171,800
-171,800
-12,700
-140,600
-68,900
Basic EPS
-1.16
--
-0.09
-1.04
-0.52
Diluted EPS
-1.16
--
-0.09
-1.04
-0.52
Basic Average Shares
136,875
--
135,300
134,500
133,600
Diluted Average Shares
136,875
--
135,300
134,500
133,600
Total Operating Income as Reported
112,900
112,900
151,900
78,900
410,400
Total Expenses
4,061,500
4,061,500
4,371,500
4,330,200
3,538,300
Net Income from Continuing & Discontinued Operation
-171,800
-171,800
-12,700
-140,600
-68,900
Normalized Income
1,803
1,803
97,510
-82,532.60
7,800
Interest Expense
187,800
187,800
173,800
156,000
125,000
Net Interest Income
-187,800
-187,800
-173,800
-156,000
-125,000
EBIT
107,100
107,100
165,500
16,900
383,700
EBITDA
433,000
433,000
525,000
355,500
695,900
Reconciled Cost of Revenue
2,830,700
2,830,700
2,975,200
2,996,200
2,722,500
Reconciled Depreciation
325,900
325,900
359,500
338,600
312,200
Net Income from Continuing Operation Net Minority Interest
-160,700
-160,700
-4,400
-130,900
-130,900
Total Unusual Items Excluding Goodwill
-205,700
-205,700
-129,000
-51,400
-190,000
Total Unusual Items
-205,700
-205,700
-129,000
-51,400
-190,000
Normalized EBITDA
638,700
638,700
654,000
406,900
885,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-43,197
-43,197
-27,090
-3,032.60
-51,300
12/31/2021 - 10/17/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APNHF Aspen Pharmacare Holdings Limited
12.25
0.00%
 
TKDA.F Takeda Pharmaceutical Company Limited
12.80
+3.23%
 
RDDA.F Dr. Reddy's Laboratories Limited
12.00
0.00%
 
PCRX Pacira BioSciences, Inc.
25.84
-1.64%
 
AQST Aquestive Therapeutics, Inc.
2.5800
+8.86%
 
TEVA Teva Pharmaceutical Industries Limited
14.16
+4.19%